|
Marketing Executive Uncovered Fraud at Bayer Corporation;
Attorney Getnick Calls Him 'Courageous, Ethical, An Inspiration'
Related News Reports:
Interview
with Neil V. Getnick about $257 million Qui Tam Settlement
with Bayer Corporation, Corporate Crime Reporter, Vol.
17 No. 16, April 21, 2003.
"Bayer
Agrees to Pay U.S. $257 Million in Drug Fraud" by Melody
Petersen, The New York Times, April 17, 2003.
"Dying executive drove landmark Medicaid case" by
Alice Dembner, The Boston Globe, April 17, 2003
"Bayer,
Glaxo Settle Medicaid Fraud Cases" by Denise Lavoie,
washingtonpost.com, April 17, 2003
"Money wasn't reason for alert on Bayer" by Jennifer
Heldt Powell, The Boston Herald, April 18, 2003
"Bayer
agrees to biggest Medicaid fraud settlement," USA Today,
4/16/2003.
"Mass.
will get $6M of Bayer, Glaxo fine" by Jennifer Heldt
Powell, Business Today.com, April 17, 2003.
"Bayer
and Glaxo Settle Medicare Fraud Allegations" by Ronald
D. White and Roger Vincent, Los Angeles Times, April 17,
2003. |
Getnick & Getnick has negotiated a $34 million qui tam whistleblower
award - a record 24 percent of the federal government's recovery
- for a marketing executive at a pharmaceutical corporation who knew
of wrongdoing at his company that cheated Medicaid out of millions
of dollars.
Getnick & Getnick negotiated the award with the Department of
Justice on behalf of the executive, who alerted the law firm about
fraudulent marketing practices at his employer, Bayer Corporation.
The client became aware that Bayer had cheated the government out
of rebates to which it was entitled. He tried to have Bayer address
his concerns internally, but they were unresponsive.
"He is amongst the new heroes of corporate America," Neil V. Getnick,
managing partner of the law firm, said of his client, who started
his career as a store pharmacist and rose through the ranks at
Bayer to become a senior marketing executive. "He did the courageous,
ethical thing and is an inspiration to any corporate employee -
from the mailroom to the boardroom - who is aware of corporate
wrongdoing and takes steps to stop it."
Bayer agreed to pay $257 million to the federal and state governments
to settle civil and criminal charges that it defrauded Medicaid.
The civil settlement brings to nearly $400 million the total that
Getnick & Getnick has helped the government recover in whistleblower
cases.
Medicaid rules require that pharmaceutical companies give Medicaid
the same discounts they give their best commercial customers. Getnick's
client reported that to skirt these requirements and avoid paying
Medicaid the 40 percent rebates it was giving its largest customers
on the antibiotic Cipro and the anti-hypertension drug Adalat CC,
Bayer engaged in what is known as private labeling, a complicated
pricing scheme. By making nominal changes to the labels on the
bottles of pills sold to the commercial customers, Bayer made it
appear that they were the customers' own private label drugs. The
government alleged that by not including the private labeling deals
in its price reports to the government, Bayer fraudulently created
the illusion that its rebate obligation to Medicaid was only 15
percent. Over time, the difference in the rebates that Bayer owed
and the rebates it paid grew to more than $100 million.
Getnick & Getnick's partners are former fraud prosecutors. Representing
whistleblowers is one of the four areas of Getnick & Getnick's
business integrity and anti-fraud litigation practice.
"Our law practice typically involves coordination with state and
federal prosecutors in parallel investigations," Getnick said. "In
the Bayer case, we formed a partnership with the government that
put the ill-gotten gains back where they belong, in our state and
federal treasuries. It was a privilege to work both with our client
and with the dedicated attorneys from the Justice Department."
Lesley Ann Skillen, a Getnick & Getnick partner who coordinates
the firm's qui tam practice, said that the qui tam law - known
as the False Claims Act - is precisely for cases like this.
"He was a true insider," Skillen said of the firm's client. "He
showed that Bayer's corporate culture elevated short-term gain
over ethics and the law. He was crucial to proving the government's
case that the company defrauded the treasury."
The False Claims Act is a Lincoln-era law that allows private
citizens with knowledge of fraud on the government to sue and share
in the proceeds of any recovery. The law was enacted to combat
widespread procurement fraud in the Civil War, but it fell into
disuse in the 1940s. Amendments passed in 1986 made the False Claims
Act the government's chief weapon in the war on fraud, and the
Justice Department used it in its investigations of clinical laboratories
in the mid-Nineties, resulting in more than $1 billion being returned
to the treasury.
"The message for corporate America is that by championing integrity
and transparency, corporations can improve their bottom line, maintain
a positive image, and avoid legal problems. As long as you have
companies conducting themselves unethically - and not addressing
employees' legitimate concerns when wrongdoing is uncovered - there
will be whistleblowers keeping the system honest," Getnick said.

|